Neurovision Imaging Eye Test Spots Alzheimer’s Years Before Symptoms
Although there aren’t any reliable treatments for Alzheimer’s disease, being able to diagnose it years before the onset of symptoms would allow the development of new early-term therapies that are currently impossible to even try out. A new device for imaging the eye developed at Cedars-Sinai Medical Center has now been used to effectively screen patients for Alzheimer’s with impressive accuracy.
Being commercialized into a product by NeuroVision Imaging, in the initial group of 40 patients studied, the device had zero false negatives and 81% of those without the disease were confirmed to be so. It’s used to spot retinal beta-amyloid plaque that’s initially stained using curcumin, a part of turmeric, without having to take any samples from fragile parts of the nervous system. The researchers believe that because of the early deposition of beta-amyloid plaque within the retina, the test may be able to spot Alzheimer’s up to 20 years before a clinical diagnosis.
Source:NeuroVision Imaging